U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Name Type Language
ONASEMNOGENE ABEPARVOVEC
INN   USAN  
Official Name English
DNA (SYNTHETIC ADENO-ASSOCIATED VIRUS 9 VECTOR SCAAV9.CB.HSMN HUMAN SURVIVOR MOTOR NEURON PROTEIN-SPECIFYING)
Systematic Name English
NON-REPLICATING RECOMBINANT SELF-COMPLEMENTARY (SC) ADENO-ASSOCIATED VIRUS SEROTYPE 9 (AAV9) VECTOR CONTAINING THE CDNA OF THE SURVIVAL OF MOTOR NEURON 2 (SMN2) GENE UNDER THE CONTROL OF THE HYBRID CYTOMEGALOVIRUS (CMV) ENHANCER/CHICKEN BETA-ACTIN PROMOT
Common Name English
ONASEMNOGENE ABEPARVOVEC [USAN]
Common Name English
AVXS-101
Code English
ZOLGENSMA
Brand Name English
ONASEMNOGENE ABEPARVOVEC [WHO-DD]
Common Name English
ONASEMNOGENE ABEPARVOVEC [INN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 444714
Created by admin on Sat Jun 26 18:54:24 UTC 2021 , Edited by admin on Sat Jun 26 18:54:24 UTC 2021
Code System Code Type Description
DRUG CENTRAL
5332
Created by admin on Sat Jun 26 18:54:24 UTC 2021 , Edited by admin on Sat Jun 26 18:54:24 UTC 2021
PRIMARY
DRUG BANK
DB15528
Created by admin on Sat Jun 26 18:54:24 UTC 2021 , Edited by admin on Sat Jun 26 18:54:24 UTC 2021
PRIMARY
INN
10619
Created by admin on Sat Jun 26 18:54:24 UTC 2021 , Edited by admin on Sat Jun 26 18:54:24 UTC 2021
PRIMARY
CAS
1922968-73-7
Created by admin on Sat Jun 26 18:54:24 UTC 2021 , Edited by admin on Sat Jun 26 18:54:24 UTC 2021
PRIMARY
FDA UNII
MLU3LU3EVV
Created by admin on Sat Jun 26 18:54:24 UTC 2021 , Edited by admin on Sat Jun 26 18:54:24 UTC 2021
PRIMARY
NCI_THESAURUS
C174715
Created by admin on Sat Jun 26 18:54:24 UTC 2021 , Edited by admin on Sat Jun 26 18:54:24 UTC 2021
PRIMARY
RXCUI
2170226
Created by admin on Sat Jun 26 18:54:24 UTC 2021 , Edited by admin on Sat Jun 26 18:54:24 UTC 2021
PRIMARY